Marek's disease - A model for herpesvirus oncology

Critical Reviews in Microbiology

Volumn 12, Issue 4, 1985, Pages 293-320

  Calnek, B W ^a   Witter, Richard L ^b  

^a Department of Avian and Aquatic Animal Medicine New York State College of Veterinary Medicine Cornell University ^*  (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2;

ANIMAL; AVIAN LYMPHOMATOSIS HERPETOVIRUS; BIRD DISEASE; CELL TRANSFORMATION; CYTOPATHOGENIC EFFECT; DISEASE MODEL; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE; LYMPHOMA; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; TIME; VIRUS CELL TRANSFORMATION; VIRUS REPLICATION;

ANIMAL; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CYTOPATHOGENIC EFFECT, VIRAL; DISEASE MODELS, ANIMAL; HERPESVIRUS 2, GALLID; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNE TOLERANCE; IMMUNITY, NATURAL; LYMPHOCYTES; LYMPHOMA; MAREK DISEASE; TIME FACTORS; VIRUS REPLICATION;

EID: 0022568124     PISSN: 1040841X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10408418509104432     Document Type: Article

References (181)

1. Pathogenesis of Marek's disease
2. Marek's disease virus and lymphoma
3. Biology of Marek's disease virus and the herpesvirus of turkeys
4. Marek's disease
5. Multiple Nervenentzundung (Polyneuritis) bei Huhnern
6. The role of Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma
7. Oncogenic potential of herpes-simplex viruses and their association with cervical neoplasia
8. The Lucke tumor and its herpesvirus
9. Simian herpesviruses and their oncogenic properties
10. Induction of lymphoid hyperplasia and lymphoma like disease in cottontail rabbits by herpesvirus sylvilagus
11. Pathogenesis of Marek's disease
12. Further characterization of Marek's disease virus-infected lymphocytes. I. In vivo infection
13. Characterization of Marek's disease virus-infected lymphocytes: discrimination between cytolytically and latently infected cells
14. T lymphoblastoid cell lines from Marek's disease lymphomas
15. Demonstration of a tumor-associated surface antigen in Marek's disease
16. Pathogenesis of Marek's disease: early appearance of Marek's disease tumor-associated surface antigen in infected chickens
17. Fowl immunoglobulins: quantitation and antibody activity during Marek's disease in genetically resistant and susceptible birds
18. Cell-mediated cytotoxic response to cells bearing Marek's disease tumor-associated surface antigen in chickens infected with Marek's disease virus
19. Cell-mediated immunity in Marek's disease: cytotoxic responses in resistant and susceptible chickens and relation to disease
20. Marek's disease: effect of virus pathogenicity and genetic susceptibility on responses of peripheral blood lymphocytes to concanavalin-A
21. Ontogeny and line differences in the mitogenic response of chicken lymphocytes
22. Suppression and enhancement of mitogen response in chickens infected with Marek's disease virus and the herpesvirus of turkeys
23. Effects of lymphocytes from Marek's disease-infected chickens on mitogen responses of syngeneic normal chicken spleen cells
24. Host resistance factors: immune responses — a review
25. Nature of genetic resistance to Marek's disease
26. Avian major histocompatibility complex
27. Latent infections with Marek's disease virus and turkey herpesvirus
28. Fractionation of Marek's disease virus induced lymphoma by velocity sedimentation and association of infectivity with cellular fractions with and without tumor antigen expression
29. Biochemistry of Epstein-Barr virus
30. Herpetic latency and reactivation
31. Limited transcription of the herpes simplex virus genome when latent in human sensory ganglia
32. Epstein-Barr virus specific RNA. II. Analysis of polyadenylated viral RNA in restringent, abortive and productive infection
33. Marek's disease as a model for the Landry-Guillain-Barre Syndrome: latent viral infection in nonneuronal cells accompanied by specific immune responses to peripheral nerve and myelin
34. Latent herpesvirus infection of testes and spinal ganglia of turkeys with semen abnormalities
35. Ubiquity and persistence of Marek's disease virus in tumoral and non-tumorous explants
36. Cell culture techniques for primary isolation of Marek's disease associated herpesvirus
37. Long term studies of Marek's disease infection in individual chickens
38. Localization of viral antigen in chickens infected with Marek's disease herpesvirus
39. Pathogenesis of Marek's disease: early distribution of virus and viral antigens in infected chickens
40. Pathogenesis of Marek's disease in chicks with and without maternal antibody
41. In vitro stimulation of blood lymphocytes by phytohaemagglutinin during the development of Marek's disease
42. Biphasic immunosuppression in chickens infected with Marek's disease virus
43. Comparative effects of host and viral factors on early pathogenesis of Marek's disease
44. 2 in Marek's disease
45. Analysis of T and B cells of lymphomas in chickens
46. The presence of immunologically uncommitted bursa and thymus dependent lymphoid cells in the lymphomas of Marek's disease
47. Sequential changes in the numbers of B and T lymphocytes and other leukocytes in the blood in Marek's disease
48. Two lymphoblastoid cell lines from Marek's disease
49. Detection of T-cell surface determinants in three Marek's disease lymphoblastoid cell lines
50. Demonstration of Marek's disease tumor-associated surface antigen (MATSA) on six ceil lines derived from Marek's disease lymphomas
51. A nonproducer T lymphoblastoid cell line from Marek's disease transplantable tumor (JMV)
52. Spontaneous and induced herpesvirus genome expression in MD tumor cell lines
53. Establishment of Marek's disease lymphoblastoid cell lines from transplantable versus primary lymphomas
54. Expression of virus-specific, thymus-specific and tumour-specific antigens in lymphoblastoid cell lines derived from Marek's disease lymphomas
55. Demonstration of chicken fetal antigen (CFA) on normal splenic lymphocytes, Marek's disease lymphoblastoid cell lines and other neoplasms
56. The occurrence of chicken foetal antigen after infection with Marek's disease virus in three strains of chickens
57. Expression of Forssman antigen on avian lymphoblastoid cell lines transformed by Marek's disease virus or avian leukosis virus
58. Clonal variation and functional correlation of organ specific metastasis and an organ specific metastasis associated antigen
59. Hanganutziu and Deicher type heterophile antigen expressed on the surface of Marek's disease lymphoma
60. Surface antigens on Marek's disease lymphoblastoid tumor cell lines, /
61. Properties of Marek's disease tumor-associated surface antigen on MSB-1 cells
62. The expression of Marek's disease tumor-associated surface antigen in various avian species
63. Serological characterization of Marek's disease tumour-associated surface antigens on Marek's disease lymphoma cells and on cell lines derived from Marek's disease lymphomas
64. Antigenic dissimilarity of cell surface antigens of two Marek's disease lymphoma-derived cell lines (MSB-1 and RPL-1)
65. Antigenic differences between Marek's disease tumor-associated surface antigens of MSB-1 and RPL-1 line cells derived from Marek's disease lymphoma
66. Characterization of an antigen associated with the Marek's disease lymphoblastoid cell line MSB-1
67. Demonstration of Marek's disease tumor-associated surface antigen in chickens infected with, nononcogenic Marek's disease virus and herpesvirus of turkeys
68. Marek's disease tumour-specific antigen (MATSA) induced by the herpesvirus of turkeys (HVT) in vaccinated chickens
69. Marek's disease tumor-associated surface antigens (MATSA) induced in inoculated chickens by vaccines against Marek's disease
70. The tissue distribution of cells expressing tumor antigens in chickens infected with Marek's disease virus or the herpesvirus of turkeys: evidence for spontaneous remission
71. Chronological study of ultrastructural changes in the peripheral nerves in Marek's disease
72. Studies on Marek's Disease. II. Pathogenesis
73. Molecular biology of Marek's disease virus — a review
74. Deoxyribonucleic acid of Marek's disease virus in virus-induced tumors
75. Marek's disease virus DNA in a chicken lymphoblastoid cell line (MSB-1) and in virus-induced tumors
76. Deoxyribonucleic acid of Marek's disease virus in a lymphoblastoid cell line from Marek's disease tumours
77. Persistence of viral DNA in Marek's disease virus-transformed lymphoblastoid cell lines
78. Biochemical evidence of the nonintegrated status of Marek's disease virus DNA in virus-transformed lymphoblastoid cells of chickens
79. Intracellular state of Marek's disease virus DNA in two tumor-derived chicken cell lines
80. Circular forms of viral DNA in Marek's disease virus-transformed lymphoblastoid cells
81. DNA of a chicken herpesvirus is associated with at least two chromosomes in a chicken lymphoblastoid cell line
82. Transcription of the Marek's disease virus genome in a nonproductive chicken lymphoblastoid cell line
83. Induction of Marek's disease virus antigens by IUdR in a chicken lymphoblastoid cell line
84. Marek's disease virus-induced atherosclerosis and evidence for a herpesvirus role in human vascular disease
85. Viruses in the etiology of atherosclerosis
86. Cytomegalovirus antigen within human arterial smooth muscle cells
87. Influence of the bursa of Fabricius on the pathogenesis of Marek's disease
88. Immunodeficiency in the chicken. I. Disparity in suppression of antibody responses to various antigens following surgical bursectomy
89. Further characterization of Marek's disease virus-infected lymphocytes. II. In vitro infection
90. Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus
91. Characterization of nononcogenic Marek's disease virus-infected and turkey herpesvirus-infected lymphocytes
92. In vitro infection of T-Iymphocytes with Marek's disease virus
93. Characteristics of the virus
94. Herpes simplex virus infection of human T-cell subpopulations
95. Replication of herpes simplex virus in human peripheral blood lymphocytes
96. In vitro infection of lymphocytes with Marek's disease virus
97. Maintenance of latent herpetic infection: an apparent role for antiviral IgG
98. The structure of Marek's disease virus genome and identification of possible tumor inducing gene of the virus
99. Structure of Marek's disease virus DNA: detailed restriction enzyme map
100. Restriction enzyme analysis of MDV DNA and homology between strains (II)
101. Genetic relatedness of virulent and avirulent strains of Marek's disease virus
102. Expression of genetic resistance to an oncogenic herpesvirus at the target cell level
103. The mechanism of genetic resistance to Marek's disease in chickens
104. Use of an agar culture technique for establishing lymphoid cell lines from Marek's disease lymphomas
105. Biochemical evidence of the non-integrated status of Marek's disease virus DNA in virus-transformed cells of the chicken
106. The molecular biology of Marek's disease herpesvirus
107. Transplantable Marek's disease lymphomas. II. Variable tumor immunity induced by different lymphoblastoid cells
108. Induction of an early antigen of Marek's disease virus in a lymphoblastoid cell line
109. Activation of Epstein-Barr virus by 5-bromodeoxyuridine in “virus-free” human cells
110. Synthesis of Epstein-Barr virus after activation of the viral genome in a “virus negative” human lymphoblastoid cell (Raji) made resistant to 5-bromodeoxyuridine
111. Syngeneic and allogeneic cell-mediated cytotoxicity against Marek's disease lymphoblastoid tumor cell lines
112. The role of histocompatibility antigens in cell-mediated cytotoxicity against Marek's disease tumor-derived lymphoblastoid cell lines
113. In vitro cytotoxicity against Marek's disease lymphoblastoid cell lines after enzymatic removal of Marek's disease tumor-associated surface antigen
114. Impairment of stimulation by mitogens of lymphocytes from Marek's disease infected chickens: detection and role of a thymic factor
115. Effects of vaccination for Marek's disease on growth of a Marek's virus-induced transplantable lymphoma in syngeneic and allogeneic chickens
116. Pathogenicity of variant Marek's disease virus isolants in vaccinated and unvaccinated chickens
117. Effect of virus pathogenicity on antibody production in Marek's disease
118. Depression of in vitro responsiveness to phy-tohemagglutinin in spleen cells cultured from chickens with Marek's disease
119. Suppression of mitogen-induced proliferation of normal spleen cells by macrophages from chickens inoculated with Marek's disease virus
120. Inhibition of natural killer activity in chickens by Marek's disease virus-transformed cell lines
121. Genetic resistance
122. Marek's disease — a common naturally herpesvirus-induced lymphoma of the chicken
123. Comparative features of low-virulence and high-virulence Marek's disease virus infections
124. Studies on acute Marek's disease. I. Characteristics of isolate GA in chickens
125. Characterization of two highly oncogenic strains of Marek's disease virus
126. Influence of oncogenicity of Marek's disease virus on evaluation of genetic resistance
127. Subpopulations of suppressor cells in chickens infected with cells of a transplantable lymphoblastic leukemia
128. The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek's disease (strain HPRS-16) on passage in cell culture
129. Pathogenesis of infection with attenuated Marek's disease virus strains
130. Characteristics of Marek's disease isolated from vaccinated commercial chicken flocks: association of viral pathotype with lymphoma frequency
131. Pathogenicity of low-virulence Marek's disease viruses in normal versus immunologically compromised chickens
132. Resistance to Marek's disease in immunologically deficient chickens
133. Absence of age-resistance in neonatally thymec-tomized chickens as evidence for cell-mediated immune surveillance in Marek's disease
134. Reduced incidence of Marek's disease gross lymphomas in T-cell-depleted chickens
135. Chromosomal localization of the major histocompatibility (B) locus in the chicken
136. A three-locus model for the chicken major histocompatibility complex
137. The structure of the major histocompatibility complex of the chicken
138. Immune response and disease resistance in chickens. II. Marek's disease and immune response to GAT
139. Modification of Marek's disease pathogenesis by in' ovo infection or prior vaccination
140. In ovo assay for Marek's disease virus and turkey herpesvirus
141. Non-MHC-associated genetic resistance to Marek's disease: expression at the target cell level
142. Chicken lymphocyte alloantigen genes and responsiveness of whole blood cells to Concanavalin A
143. Modification by herpesvirus of hereditary GVHR competency
144. Cellular immune response to Marek's disease: listeriosis as a model of study
145. Antibody development in chickens exposed to Marek's disease virus
146. Synthesis of immunoglobulin and Marek's disease virus antibody in susceptible and relatively resistant chickens
147. Serum neutralizing antibody development and host resistance in chickens exposed to Marek's disease infection
148. Genetic resistance to Marek's disease. Delineation of the response of genetically resistant chickens to Marek's disease virus infection
149. Fowl immunoglobulins: quantitation in birds genetically resistant and susceptible to Marek's disease
150. Immunization against Marek's disease: influence of strain of chickens, maternal antibody, and type of vaccine
151. Comparison of indirect hemagglutination and immunodiffusion tests for detecting type II leukosis (Marek's) infection in S- and K-line chickens
152. Natural killer cell activity in chickens exposed to Marek's disease virus: inhibition of activity in susceptible chickens and enhancement of activity in resistant and vaccinated chickens
153. Some effects of silica treatment on Marek's disease
154. The role of macrophages in Marek's disease: in vitro and in vivo studies
155. Macrophage restriction of Marek's disease virus replication and lymphoma cell proliferation
156. Inhibitory effects of macrophages against Marek's disease virus plaque formation in chicken kidney cell cultures
157. In vitro inactivation of cell-free Marek's disease herpesvirus by immune peripheral blood lymphocytes
158. Cytotoxic effector cells specific for B cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis
159. Evidence for anti-viral, T-cell mediated immunity in Marek's disease
160. A monoclonal antibody reactive with Marek's disease tumor-associated surface antigen
161. The effect of maternal antibody on Marek's disease
162. Influence of maternal antibody on infection with virulent and attenuated Marek's disease herpesvirus
163. Effect of passively transferred immunoglobulins on Marek's disease
164. Vaccinal immunity to Marek's disease in bursectomized chickens
165. Vaccination of bursectomized chickens with inactivated Marek's disease virus-specific antigens
166. Transient effect of cyclophosphamide on vaccinal immunity to Marek's disease
167. Amelioration of Marek's disease and absence of vaccine protection in immunologically deficient chickens
168. Antiviral immunity against Marek's disease virus infected chicken kidney cells
169. Mechanism of protection conferred by HVT
170. Pathogenesis of Marek's disease: effect of immunization with inactivated viral and tumor-associated antigens
171. Dissociation of anti-viral and anti-tumor immunity in resistance to Marek's disease
172. High-virulence Marek's disease virus infection in chickens previously infected with low-virulence virus
173. Bursal lesions in chickens inoculated with Marek's disease vaccines
174. Preservation of a thymus derived cell mediated immune response in Marek's disease virus infected chickens by vaccination with a related virus
175. Rejection of a transplantable Marek's disease lymphoma in normal versus immunologically deficient chickens
176. The effect of B-cell immunosuppression on age-related resistance of chickens to Marek's disease
177. Effect of cyclophosphamide on the response of chickens to a virulent strain of Marek's disease virus